Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Musto, Pellegrino ^b   Bardi, Antonella ^a   Cavazzini, Francesco ^a   Rigolin, Gian Matteo ^a   Tammiso, Elisa ^a   Volta, Eleonora ^a   Pezzolo, Elisa ^a   Formigaro, Luca ^a   Sofritti, Olga ^a   Daghia, Giulia ^a   Ambrosio, Cristina ^a   Rizzotto, Lara ^a   Abass, Awad E ^a   D'Auria, Fiorella ^b   Cuneo, Antonio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; OLIGODEOXYNUCLEOTIDE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; LYMPHOMA CELL LINE; MALE; MITOGENESIS; MITOSIS; SPLENIC MARGINAL ZONE LYMPHOMA; TRISOMY 12; GENETICS; MARGINAL ZONE LYMPHOMA; METHODOLOGY; MIDDLE AGED; OLIGONUCLEOTIDE PROBE; SPLEEN TUMOR;

AGED; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; INTERLEUKIN-2; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; SPLENIC NEOPLASMS;

EID: 80052680854     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/691493     Document Type: Article

References (33)

1. Swerdlow S. H., Campo E., Harris N. L., World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France International Agency for Research on Cancer
2. Franco V., Florena A. M., Iannitto E., Splenic marginal zone lymphoma Blood 2003 101 7 2464 2472 (Pubitemid 36857599)
3. Oscier D. G., Matutes E., Gardiner A., Glide S., Mould S., Brito-Babapulle V., Ellis J., Catovsky D., Cytogenetic studies in splenic lymphoma with villous lymphocytes British Journal of Haematology 1993 85 3 487 491 (Pubitemid 23349050)
4. Dierlamm J., Michaux L., Wlodarska I., Pittaluga S., Zeller W., Stul M., Criel A., Thomas J., Boogaerts M., Delaere P., Cassiman J. J., De Wolf-Peeters C., Mecucci C., Van Den Berghe H., Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization British Journal of Haematology 1996 93 1 242 249 (Pubitemid 26130733)
5. Solé F., Woessner S., Florensa L., Espinet B., Mollejo M., Martn P., Piris M. A., Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma British Journal of Haematology 1997 98 2 446 449 (Pubitemid 27345125)
6. Solé F., Salido M., Espinet B., Garcia J. L., Climent J. A. M., Granada I., Hernndez J. M., Benet I., Piris M. A., Mollejo M., Martinez P., Vallesp T., Domingo A., Serrano S., Woessner S., Florensa L., Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q Haematologica 2001 86 1 71 77 (Pubitemid 32147054)
7. Gazzo S., Baseggio L., Coignet L., Poncet C., Morel D., Coiffier B., Felman P., Berger F., Salles G., Callet-Bauchu E., Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma Haematologica 2003 88 1 31 38 (Pubitemid 36168852)
8. Cuneo A., Bigoni R., Roberti M. G., Milani R., Agostini P., Cavazzini F., Minotto C., De Angeli C., Bardi A., Tammiso E., Negrini M., Cavazzini P., Castoldi G., Molecular cytogenetic characterization of marginal zone B-cell lymphonia: correlation with clinicopathologic findings in 14 cases Haematologica 2001 86 1 64 70 (Pubitemid 32147053)
9. Troussard X., Mauvieux L., Radford-Weiss I., Rack K., Valensi F., Garand R., Vekemans M., Flandrin G., Macintyre E. A., Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d'Hematologie Cellulaire (GFHC) study British Journal of Haematology 1998 101 4 712 721 (Pubitemid 28308521)
10. Hernndez J. M., Garca J. L., Gutiérrez N. C., Mollejo M., Martnez-Climent J. A., Flores T., Gonzlez M. B., Piris M. A., San Miguel J. F., Novel genomic imbalances in b-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics American Journal of Pathology 2001 158 5 1843 1850 (Pubitemid 32422949)
11. Vega F., Cho-Vega J. H., Lennon P. A., Luthra M. G., Bailey J., Breeden M., Jones D., Medeiros L. J., Luthra R., Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes British Journal of Haematology 2008 142 2 216 226 (Pubitemid 351987320)
12. James Watkins A., Huang Y., Ye H., Chanudet E., Johnson N., Hamoudi R., Liu H., Dong G., Attygalle A., McPhail E. D., Law M. E., Isaacson P. G., De Leval L., Wotherspoon A., Du M. Q., Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis Journal of Pathology 2010 220 4 461 474
13. Salido M., Bar C., Oscier D., Stamatopoulos K., Dierlamm J., Matutes E., Traverse-Glehen A., Berger F., Felman P., Thieblemont C., Gesk S., Athanasiadou A., Davis Z., Gardiner A., Milla F., Ferrer A., Mollejo M., Calasanz M. J., Florensa L., Espinet B., Luo E., Wlodarska I., Verhoef G., Garca-Granero M., Salar A., Papadaki T., Serrano S., Piris M. A., Solé F., Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group Blood 2010 116 9 1479 1488
14. Dicker F., Schnittger S., Haferlach T., Kern W., Schoch C., Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80 of CLL patients: a study of 132 CLL cases with correlation to FISH, Ig V H status, and CD38 expression Blood 2006 108 9 3152 3160
15. Haferlach C., Dicker F., Schnittger S., Kern W., Haferlach T., Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, Ig V H status and immunophenotyping Leukemia 2007 21 12 2442 2451 (Pubitemid 350148886)
16. Mollejo M., Menarguez J., Lloret E., Sanchez A., Campo E., Algara P., Cristobal E., Sanchez E., Piris M. A., Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma: a clinicopathological study of 13 cases American Journal of Surgical Pathology 1995 19 10 1146 1157
17. Matutes E., Oscier D., Montalban C., Berger F., Callet-Bauchu E., Dogan A., Felman P., Franco V., Iannitto E., Mollejo M., Papadaki T., Remstein E. D., Salar A., Solé F., Stamatopoulos K., Thieblemont C., Traverse-Glehen A., Wotherspoon A., Coiffier B., Piris M. A., Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria Leukemia 2008 22 3 487 495 (Pubitemid 351386718)
18. Castoldi G. L., Lanza F., Cuneo A., Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens Cancer Genetics and Cytogenetics 1987 26 1 75 84 (Pubitemid 17066682)
19. Rooney D. E., Human Cytogenetics: Malignancy and Acquired Abnormalities 2001 Oxford university Press
20. Karger M. F., Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetics Nomenclature ISCN. Basel, Switzerland, 2005
21. Hernandez J. M., Mecucci C., Criel A., Meeus P., Michaux L., Van Hoof A., Verhoef G., Louwagie A., Scheiff J. M., Michaux J. L., Boogaerts M., Van Den Berghe H., Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria Leukemia 1995 9 12 2140 2146
22. Gruszka-Westwood A. M., Hamoudi R. A., Matutes E., Tuset E., Catovsky D., p53 abnormalities in splenic lymphoma with villous lymphocytes Blood 2001 97 11 3552 3558
23. Zenz T., Dhner H., Stilgenbauer S., Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia Best Practice and Research 2007 20 3 439 453 (Pubitemid 47250492)
24. Juliusson G., Oscier D. G., Fitchett M., Ross F. M., Stockdill G., Mackie M. J., Parker A. C., Castoldi G. L., Cuneo A., Knuutila S., Elonen E., Gahrton G., Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities New England Journal of Medicine 1990 323 11 720 724 (Pubitemid 20288941)
25. Haferlach C., Dicker F., Weiss T., Schnittger S., Beck C., Grote-Metke A., Oruzio D., Kern W., Haferlach T., Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters Genes Chromosomes and Cancer 2010 49 9 851 859
26. Buhmann R., Kurzeder C., Rehklau J., Westhaus D., Bursch S., Hiddemann W., Haferlach T., Hallek M., Schoch C., CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells British Journal of Haematology 2002 118 4 968 975 (Pubitemid 35025958)
27. Heerema N. A., Byrd J. C., Dal Cin P. S., Dell' Aquila M. L., Koduru P. R.K., Aviram A., Smoley S. A., Rassenti L. Z., Greaves A. W., Brown J. R., Rai K. R., Kipps T. J., Kay N. E., Van Dyke D. L., Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study Cancer Genetics and Cytogenetics 2010 203 2 134 140
28. Meloni-Ehrig A., Meck J., Christacos N., Kelly J., Matyakhina L., Schonberg S., Stimulation of B-cell mature malignancies with the CpG-oligonucleotide DSP30 and interleukin-2 for improved detection of chromosome abnormalities Blood 2009 114. ASH Annual Meeting Abstracts. Abs no. 1955
29. Reindl L., Bacher U., Dicker F., Alpermann T., Kern W., Schnittger S., Haferlach T., Haferlach C., Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms British Journal of Haematology 2010 151 1 25 36
30. Martn-Subero J. I., Ibbotson R., Klapper W., Michaux L., Callet-Bauchu E., Berger F., Calasanz M. J., De Wolf-Peeters C., Dyer M. J., Felman P., Gardiner A., Gascoyne R. D., Gesk S., Harder L., Horsman D. E., Kneba M., Kppers R., Majid A., Parry-Jones N., Ritgen M., Salido M., Solé F., Thiel G., Wacker H. H., Oscier D., Wlodarska I., Siebert R., A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation Leukemia 2007 21 7 1532 1544 (Pubitemid 46969871)
31. Huh Y. O., Abruzzo L. V., Rassidakis G. Z., Parry-Jones N., Schlette E., Brito-Bapabulle V., Matutes E., Wotherspoon A., Keating M. J., Medeiros L. J., Catovsky D., The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases British Journal of Haematology 2007 136 2 220 228 (Pubitemid 46020749)
32. Michaux L., Dierlamm J., Wlodarska I., Bours V., Van Den Berghe H., Hagemeijer A., t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases Cancer Genetics and Cytogenetics 1997 94 1 36 43 (Pubitemid 27133499)
33. Robledo C., Garca J. L., Caballero D., Conde E., Arranz R., Flores T., Grande C., Rodrguez J., Garca E., Sez A. I., Gonzlez M., Gutiérrez N. C., Piris M. A., Hernndez J. M., Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas Cancer 2009 115 16 3728 3737.